BMT Tandem "Scientific" Meeting
Seaport Ballroom DE (Manchester Grand Hyatt)
Chairs:
John Koreth, MBBS, DPhil
and
Pavan Reddy, MD
Disclosures:
J. Koreth,
Nothing To Disclose
P. Reddy,
Nothing To Disclose
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Mukta Arora, MD, MS, University of Minnesota Medical Center;
Corey S. Cutler, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Madan H. Jagasia, MD, MBBS, MS, Vanderbilt University Medical Center;
Joseph Pidala, MD, PhD, H. Lee Moffitt Cancer Center and Research Institute;
Xiaoyu Chai, MS, Fred Hutchinson Cancer Research Center;
Paul J. Martin, MD, Fred Hutchinson Cancer Research Center;
Mary E. D. Flowers, MD, Fred Hutchinson Cancer Research Center;
Yoshihiro Inamoto, MD PhD, National Cancer Center Hospital;
George L Chen, MD, Roswell Park Cancer Institute;
Bill Wood, University of North Carolina at Chapel Hill;
Nandita Khera, MD, Mayo Clinic;
Jeanne Palmer, MD, Mayo Clinic Arizona;
Hien K. Duong, MD, Cleveland Clinic;
Sally Arai, MD, Stanford University Medical Center;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Birgitta Versluys, MD, University Medical Center Utrecht;
Marc Bierings, MD, PhD, University Medical Center Utrecht;
Caroline A. Lindemans, MD, PhD, University Medical Center Utrecht;
Kors Ent vd, Md, PhD, Wilhelmina Kinderziekenhuis, University Medical Center Utrecht;
Tom Wolfs, MD, PhD, Wilhelmina Kinderziekenhuis, University Medical Center Utrecht;
Jean Luc Murk, MD, PhD, University Medical Center Utrecht;
Jaap-Jan Boelens, MD, PhD, University Medical Center Utrecht
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Claudio G. Brunstein, MD, PhD, University of Minnesota Medical Center;
Keli Hippen, University of Minnesota;
Todd E Defor, MS, University of Minnesota;
David McKenna, MD, University of Minnesota;
Julie Curtsinger, University of Minnesota;
Darin Sumstad, University of Minnesota Medical Center, Fairview;
Bruce L Levine, PhD, University of Pennsylvania;
Carl H. June, MD, University of Pennsylvania;
Jeffrey S. Miller, MD, University of Minnesota;
Michael R. Verneris, MD, University of Minnesota Medical Center, Fairview;
Bruce R. Blazar, MD, University of Minnesota;
John E. Wagner, MD, University of Minnesota
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
Scott N Furlan, MD, Seattle Children's Research Institute;
Benjamin K. Watkins, MD, Emory University;
Angela Mortari, University of Minnesota;
Bruce R. Blazar, MD, University of Minnesota;
Cynthia Giver, Emory University;
Edmund K. Waller, MD, PhD, Emory University;
Leslie S. Kean, MD, PhD, Fred Hutchinson Cancer Research Center
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Shernan Holtan, MD, University of Minnesota;
Michael R. Verneris, MD, University of Minnesota;
Kirk R. Schultz, MD, BC Childrens Hospital;
Laura F Newell, MD, Oregon Health & Science University;
Gabrielle Meyers, MD, Oregon Health & Science University;
Fiona He, MD, University of Minnesota;
Todd E Defor, MS, University of Minnesota;
Margaret L. MacMillan, MD, MSc, FRCPC, University of Minnesota;
Sarah Cooley, MD, University of Minnesota;
Bruce R. Blazar, MD, University of Minnesota;
Angela Panoskaltsis-Mortari, PhD, University of Minnesota;
Daniel J. Weisdorf, MD, University of Minnesota Medical Center
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Caroline A. Lindemans, MD, PhD, University Medical Center Utrecht;
Anna Mertelsmann, Memorial Sloan Kettering Cancer Center;
Margaret O'Connor, Memorial Sloan Kettering Cancer Center;
Marco Calafiore, Memorial Sloan Kettering Cancer Center;
Jarrod A Dudakov, Memorial Sloan Kettering Cancer Center;
Robert Jenq, MD, Memorial Sloan Kettering Cancer Center;
Enrico Velardi, Memorial Sloan Kettering Cancer Center;
Lauren Young, Memorial Sloan Kettering Cancer Center;
Odette M. Smith, BA, Memorial Sloan Kettering Cancer Center;
Gillian Lawrence, Memorial Sloan Kettering Cancer Center;
Natalie Luo, Memorial Sloan Kettering Cancer Center;
Juliet Ivanov, Memorial Sloan Kettering Cancer Center;
Guoqiang Hua, Memorial Sloan Kettering Cancer Center;
Laura Martin, Memorial Sloan Kettering Cancer Center;
Chen Liu, University of Florida College of Medicine;
Richard Kolesnick, Memorial Sloan Kettering Cancer Center;
Marcel R. M. van den Brink, MD, PhD, Memorial Sloan Kettering Cancer Center;
Alan M. Hanash, MD, PhD, Memorial Sloan Kettering Cancer Center
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Jeanne Palmer, MD, Mayo Clinic;
Xiaoyu Chai, MS, Fred Hutchinson Cancer Research Center;
Paul J. Martin, MD, Fred Hutchinson Cancer Research Center;
Joseph Pidala, MD, PhD, H. Lee Moffitt Cancer Center and Research Institute;
Aleksandr Lazaryan, MD MPH PhD, University of Minnesota Medical Center;
Mukta Arora, MD, MS, University of Minnesota Medical Center;
Corey S. Cutler, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Steven Z. Pavletic, MD, National Cancer Institute, National Institutes of Health;
Iskra Pusic, MD, Washington University Medical Center;
Madan H. Jagasia, MD, MBBS, MS, Vanderbilt University Medical Center;
Yoshihiro Inamoto, MD PhD, National Cancer Center Hospital;
Mary E. D. Flowers, MD, Fred Hutchinson Cancer Research Center;
Georgia Vogelsang, MD, MBA, Johns Hopkins Medical Center;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center
![[Visit Client Website]](images/banner.gif)